Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
about
Calcium, TRPC channels, and regulation of the actin cytoskeleton in podocytes: towards a future of targeted therapiesThe renal channelopathiesCell biology and pathology of podocytesCalcium regulates podocyte actin dynamics.TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseasesNOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complexInhibition of the TRPC5 ion channel protects the kidney filterPodocyte dysfunction in atypical haemolytic uraemic syndrome.Transient receptor potential (TRP) channels: a clinical perspectiveThe Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling.PKC-dependent Phosphorylation of the H1 Histamine Receptor Modulates TRPC6 Activity.Single-channel analysis of TRPC channels in the podocytes of freshly isolated GlomeruliExpression of TRPC6 in renal cortex and hippocampus of mouse during postnatal development.Non-immunologic actions of calcineurin inhibitors in proteinuric kidney diseases.Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathyActivation of RhoA in podocytes induces focal segmental glomerulosclerosis.Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.Gq signaling causes glomerular injury by activating TRPC6.Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death.Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channelsInhibition of TRPC6 by protein kinase C isoforms in cultured human podocytesRole of renal TRP channels in physiology and pathologyWnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2)20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in PodocytesTransient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.The proteoglycan syndecan 4 regulates transient receptor potential canonical 6 channels via RhoA/Rho-associated protein kinase signaling.Deletion of TRPC6 Attenuates NMDA Receptor-Mediated Ca2+ Entry and Ca2+-Induced Neurotoxicity Following Cerebral Ischemia and Oxygen-Glucose Deprivation.Tyrosine kinase signaling in kidney glomerular podocytes.Balancing calcium signals through TRPC5 and TRPC6 in podocytes.Educational paper: the podocytopathies.Animal models of nephrotic syndrome.How many Achilles' heels does a podocyte have? An update on podocyte biology.Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?Pleiotropic signaling evoked by tumor necrosis factor in podocytes.ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.Disease modeling in genetic kidney diseases: mice.
P2860
Q26778579-6223AC6E-EB13-4154-9E5A-0753261E6F16Q26824023-6F2F1072-0C9D-475A-AF29-E91C7B707604Q26853664-745EA7A5-82B5-4298-9816-FE984CF7A512Q27692627-5054BDCD-961C-4804-9D92-6800FAD28C01Q28081895-D27C5933-8D3E-4C2C-AEFD-554E1C12879CQ28296660-9A86F77A-3C10-41D1-9037-2B208B9FA317Q30559274-76C0C221-F72A-403F-8BD7-4ADEF784F8D7Q33419853-32A0F898-2CBF-4BE2-8CBD-D53E338082A6Q33562143-D1E98BC4-DEAC-4A6D-9FEC-A2E8583B1FEDQ33671746-D64A34A1-EBA5-4552-B5BD-01A0AAE61E5CQ33883861-ACC4D310-FEAA-4F0F-996D-C36FE1CC7F1FQ34273590-6B9B6CB4-9CD4-4C14-93A9-9C45C5D90CBDQ34305480-9697E9F9-2CEC-4F04-B101-ABD27BDF8218Q34496366-7BAFC7E6-D9F5-4390-921C-68AA2DFA38DFQ34674987-9FDB6669-2B5B-4457-B7C2-0E2B4810ED5BQ35206224-B3B318C5-9E37-41C7-92C9-DC97C6D89AE6Q35210190-B82A01B2-DCFA-468F-9189-54C309E7EC21Q35235668-A690C153-A57D-4A0E-80AF-EE9DDDDFD19EQ35719874-6635448E-A200-4CD2-A656-ED61CA2E11BEQ35780729-ED145FDA-BD58-4C66-8041-C02E4F35F811Q36294421-A2E41A90-9E5D-4A68-BF90-044439627EC8Q36360722-43C8A329-9FEF-4272-86A8-9941E14AEB53Q36394692-56AE23DB-B1C7-4AB2-BD9D-05F2473A443DQ36703547-93244D61-13A7-4BE9-9BA5-AAA8CE50FC4BQ36908181-1259E1D4-5779-457E-9F28-3EB55F9BBB9DQ36947844-EA700579-5498-4C33-9A1B-1DE46001D8FCQ37218316-966C7CFC-3DD1-4ED1-9C43-A9344103159DQ37405051-C0D3314A-E93F-478C-AB5C-959E8E4B5016Q37436623-1EB9C19C-35FE-4127-AB63-F522F0702288Q37723488-4A3D85C9-939E-4C31-A632-4213629E450EQ37903259-9354474A-BC6E-477E-BBF0-079FD3278C5AQ37943290-8222F08D-C5FB-4BA1-A105-53A97F3ACDC6Q37975102-6B844E69-A542-4D1F-B392-96DF345583F8Q38068358-BDF19D55-E065-4581-9A52-39EE2C3CD2B1Q38217483-12660995-8BFB-4976-98F6-013E697F841FQ38458152-95080E0D-F8FB-4AEA-A6BC-11D72EF2B916Q38870270-CE5F7535-10C9-4137-B127-01FE3A639F3FQ39022403-9E4ED65B-0F11-44D6-880D-5E59ED22D4E9Q39154682-228F2F91-3F18-4920-80EF-68557DA3B1EEQ39364606-0AF96241-5C49-4A11-9BC5-38E4B47391BC
P2860
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@ast
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@en
type
label
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@ast
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@en
prefLabel
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@ast
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@en
P2093
P2860
P1433
P1476
Podocyte-specific overexpressi ...... t to cause glomerular disease.
@en
P2093
Cesar P Canales
Changli Wei
J Daniel Carpio
Jessica Molina
Jochen Reiser
Juan I Young
Pamela Kairath
Paola Krall
Phillip Ruiz
P2860
P304
P356
10.1371/JOURNAL.PONE.0012859
P407
P577
2010-09-20T00:00:00Z